On December 2, 2019 Novocure (NASDAQ: NVCR) and the American Association for Cancer Research (AACR) (Free AACR Whitepaper) reported their 2nd Annual AACR (Free AACR Whitepaper)-Novocure Grants for Tumor Treating Fields Research program (Press release, NovoCure, DEC 2, 2019, View Source [SID1234551835]). The program represents a joint effort to promote and support innovative research on Tumor Treating Fields to help deepen the understanding of the mechanism of action and to accelerate the development of new treatment strategies. The program includes research grants and career development awards totaling more than $2 million over the next three years.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

"Our partnership with Novocure continues to break new ground toward the advancement of cancer science," said Mitch Stoller, Chief Philanthropic Officer and Vice President of Development of the AACR (Free AACR Whitepaper) Foundation. "We are grateful for Novocure’s visionary support of the AACR (Free AACR Whitepaper)’s Grants Program, and we look forward to witnessing the innovative research that will result from these important grants."

Recipients of the research grants will receive a total of $250,000 over two years. Recipients of the career development awards will receive a total of $225,000 over three years. Novocure and the AACR (Free AACR Whitepaper) encourage applicants to focus their proposals on translational approaches, promoting the transition of in vitro work into in vivo systems; combination therapies involving Tumor Treating Fields; and bringing treatments involving Tumor Treating Fields to the clinic. The application deadline is December 11. Recipients will be announced at the AACR (Free AACR Whitepaper) Annual Meeting 2020 in San Diego.

"Deepening our understanding of the mechanism of action of Tumor Treating Fields can potentially advance our efforts to extend survival in some of the most aggressive forms of cancer," said Dr. Uri Weinberg, Novocure’s Vice President of Clinical Development. "We are excited to continue our partnership with the AACR (Free AACR Whitepaper) to offer this important research program and look forward to the announcement of recipients at the AACR (Free AACR Whitepaper) Annual Meeting."

To apply for the AACR (Free AACR Whitepaper)-Novocure Grants for Tumor Treating Fields Research, visit www.aacr.org/funding.